Herrera, H, Dilday, T, Uber, A, Scott, D, Zambrano, JN, Wang, M, Angel, PM, Mehta, AS, Drake, RR, Hill, EG, and Yeh, ES. (2019) Core-fucosylated tetra-antennary N-glycan containing a single N-acetyllactosamine branch is associated with poor survival outcome in breast cancer. Int J Mol Sci. 20, 2528.
Zambrano, JN, Williams, CJ, Williams, CB, Hedgepeth, L, Burger, P, Dilday, T, Eblen, ST, Armeson, K, Hill, EG, and Yeh, ES (2018) Staurosporine, an inhibitor of Hormonally Up-regulated Neu-associated Kinase. Oncotarget 9:35962-35973.
Yeh, ES, Williams, CJ, Williams, CB, Bonilla, IV, Klauber-DeMore, N, and Phillips, SL. (2017) Dysregulated Connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration. Oncotarget. 8:109358-109369.
Zambrano, JN, Neely, BA, and Yeh, ES (2017) Hormonally Up-regulated Neu-associated Kinase: A novel target for breast cancer progression. Pharmacol Res. 119: 188-197.
Phelps-Polirer, K, Abt, MA, Smith, D, and Yeh, ES (2016) Co-targeting of JNK and HUNK in HER2-positive Breast Cancers Resistant to Trastuzumab and Lapatinib. PlosOne 11 (4): e0153025.
Grek, CL, Rhett, JM, Bruce, JS, Abt, MA, Ghatnekar, GS, and Yeh, ES (2015) Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of targeted inhibitors in breast cancer. BMC Cancer, 15: 296.
Yeh, ES, Abt, MA, and Hill, EG. (2015) Regulation of Cell Survival by HUNK Mediates Breast Cancer Resistance to HER2 Inhibitors. Breast Cancer Research and Treatment. 149 (1), 91-8.